Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Profit After Tax

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹1,883 Cr₹1,388 Cr₹715 Cr₹170 Cr₹442 Cr

What is the latest Profit After Tax of NATCO PHARMA ?

The latest Profit After Tax ratio of NATCO PHARMA is ₹1,883 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹1,883 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹442 Cr

How is Profit After Tax of NATCO PHARMA Trending?

Years Profit After Tax % Change
Mar2025 ₹1,883 Cr
35.66
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.57
Mar2021 ₹442 Cr -

Compare Profit After Tax of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,730.4 Cr 2% 6.7% -32.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,378.0 Cr 1.7% 7.3% 0% Stock Analytics
DIVIS LABORATORIES ₹171,996.0 Cr 1.8% 0.9% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,959.0 Cr 1.3% 4.4% 14.9% Stock Analytics
CIPLA ₹123,666.0 Cr 0.9% -2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,008.0 Cr 0.5% -3.1% 3.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2%

6.7%

-32.1%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses